Literature DB >> 21893662

Temporal relationship between depression and dementia: findings from a large community-based 15-year follow-up study.

Ge Li1, Lucy Y Wang, Jane B Shofer, Mary Lou Thompson, Elaine R Peskind, Wayne McCormick, James D Bowen, Paul K Crane, Eric B Larson.   

Abstract

CONTEXT: Late-life depression is associated with increased risk of dementia, but the temporal relationship between depression and development of dementia remains unclear.
OBJECTIVES: To examine the association between risk of dementia and baseline depressive symptoms; history of depression, particularly early-life (<50 years) vs late-life depression (≥50 years); and individual domains of the Center for Epidemiologic Studies Depression Scale.
DESIGN: A large cohort with initially nondemented participants was followed up biennially for up to 15 years. Baseline depressive symptoms were assessed using the 11-item version of the Center for Epidemiologic Studies Depression Scale; presence of significant depressive symptoms was defined as a score of 11 or greater. Self-reported history of depression was collected at the baseline interview. Cox proportional hazards regression was used to assess the association between depression and dementia risk.
SETTING: Population-based cohort drawn from members of the Group Health Cooperative in Seattle, Washington. PARTICIPANTS: A cohort of 3410 participants without dementia aged at least 65 years.
RESULTS: During a mean of 7.1 years of follow-up, 658 participants (19.3%) developed dementia. At baseline, 9.4% of participants had presence of significant depressive symptoms, and 21.2% reported a history of depression. The adjusted hazard ratio for dementia associated with baseline depressive symptoms was 1.71 (95% confidence interval, 1.37-2.13), after adjusting for age at entry, sex, educational level, and wave of enrollment. Compared with participants without depression history, those with late-life depression were at increased dementia risk (adjusted hazard ratio, 1.46; 95% confidence interval, 1.16-1.84), but early-life depression had no association with dementia risk (1.10 [0.83-1.47]). Depressed mood (adjusted hazard ratio, 1.48; 95% confidence interval, 1.25-1.76) and perceived performance difficulty (1.39 [1.15-1.67]) were independently associated with dementia.
CONCLUSION: This study confirmed that late-life depression is associated with increased risk of dementia and supplied evidence that late-life depression may be an early manifestation of dementia rather than increasing risk for dementia.

Entities:  

Mesh:

Year:  2011        PMID: 21893662      PMCID: PMC3289582          DOI: 10.1001/archgenpsychiatry.2011.86

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  35 in total

1.  The temporal relationship between depressive symptoms and dementia: a community-based prospective study.

Authors:  P Chen; M Ganguli; B H Mulsant; S T DeKosky
Journal:  Arch Gen Psychiatry       Date:  1999-03

2.  Generalized atherosclerosis, cognitive decline, and depressive symptoms in old age.

Authors:  D J Vinkers; M L Stek; R C van der Mast; A J M de Craen; S Le Cessie; J Jolles; R G J Westendorp; J Gussekloo
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

Review 3.  Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung.

Authors:  Alan B Shafer
Journal:  J Clin Psychol       Date:  2006-01

4.  Memory complaints in nondemented men predict future pathologic diagnosis of Alzheimer disease.

Authors:  A F Jorm; K H Masaki; D G Davis; J Hardman; J Nelson; W R Markesbery; H Petrovitch; G W Ross; L R White
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

Review 5.  'Vascular depression' hypothesis.

Authors:  G S Alexopoulos; B S Meyers; R C Young; S Campbell; D Silbersweig; M Charlson
Journal:  Arch Gen Psychiatry       Date:  1997-10

6.  Subjective memory deterioration and future dementia in people aged 65 and older.

Authors:  Li Wang; Gerald van Belle; Paul K Crane; Walter A Kukull; James D Bowen; Wayne C McCormick; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2004-12       Impact factor: 5.562

7.  Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression.

Authors:  Michael A Rapp; Michal Schnaider-Beeri; Dushyant P Purohit; Daniel P Perl; Vahram Haroutunian; Mary Sano
Journal:  Am J Geriatr Psychiatry       Date:  2008-02       Impact factor: 4.105

8.  Depressive symptoms and cognitive decline in late life: a prospective epidemiological study.

Authors:  Mary Ganguli; Yangchun Du; Hiroko H Dodge; Graham G Ratcliff; Chung-Chou H Chang
Journal:  Arch Gen Psychiatry       Date:  2006-02

9.  Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression.

Authors:  Michael A Rapp; Michal Schnaider-Beeri; Hillel T Grossman; Mary Sano; Daniel P Perl; Dushyant P Purohit; Jack M Gorman; Vahram Haroutunian
Journal:  Arch Gen Psychiatry       Date:  2006-02

10.  Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.

Authors:  Deborah E Barnes; George S Alexopoulos; Oscar L Lopez; Jeff D Williamson; Kristine Yaffe
Journal:  Arch Gen Psychiatry       Date:  2006-03
View more
  38 in total

1.  Hospitalization, depression and dementia in community-dwelling older Americans: findings from the national health and aging trends study.

Authors:  Dimitry S Davydow; Kara Zivin; Kenneth M Langa
Journal:  Gen Hosp Psychiatry       Date:  2013-12-04       Impact factor: 3.238

2.  Depression and incident Alzheimer disease: the impact of disease severity.

Authors:  Patricia Gracia-García; Concepción de-la-Cámara; Javier Santabárbara; Raúl Lopez-Anton; Miguel Angel Quintanilla; Tirso Ventura; Guillermo Marcos; Antonio Campayo; Pedro Saz; Constantine Lyketsos; Antonio Lobo
Journal:  Am J Geriatr Psychiatry       Date:  2013-06-20       Impact factor: 4.105

3.  Detecting and Managing Neuropsychiatric Symptoms in Dementia.

Authors:  Andrea Iaboni; Mark J Rapoport
Journal:  Can J Psychiatry       Date:  2017-03       Impact factor: 4.356

4.  Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition.

Authors:  Yuhai Zhang; Xiao-Hua Zhou; Dana H Meranus; Linbo Wang; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

5.  A longitudinal study of differences in late- and early-onset geriatric depression: depressive symptoms and psychosocial, cognitive, and neurological functioning.

Authors:  Natalie Sachs-Ericsson; Elizabeth Corsentino; Jerad Moxley; Jennifer L Hames; Nicole C Rushing; Kathryn Sawyer; Thomas Joiner; Edward A Selby; Steven Zarit; Ian H Gotlib; David C Steffens
Journal:  Aging Ment Health       Date:  2012-08-30       Impact factor: 3.658

6.  Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults.

Authors:  Larry Keen; Arlener D Turner
Journal:  J Behav Med       Date:  2015-03-03

7.  Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers.

Authors:  Kyle Steenland; Conny Karnes; Ryan Seals; Claudine Carnevale; Adriana Hermida; Allan Levey
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 8.  Impact of Antidepressant Use on the Trajectory of Alzheimer's Disease: Evidence, Mechanisms, and Therapeutic Implications.

Authors:  Rita Khoury; George T Grossberg
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

9.  [Depression in old age, part 1 : Origin, clinical symptoms, diagnosis and interaction between depression and dementia].

Authors:  Dirk K Wolter
Journal:  Z Gerontol Geriatr       Date:  2016-01-26       Impact factor: 1.281

10.  Late-life depression is not associated with dementia-related pathology.

Authors:  Robert S Wilson; Patricia A Boyle; Ana W Capuano; Raj C Shah; George M Hoganson; Sukriti Nag; David A Bennett
Journal:  Neuropsychology       Date:  2016-02       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.